Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04619225 · ClinicalTrials.gov registry record · NA
Cardiac Output and Recovery Time
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04619225: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04619225 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04619225, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the time it takes to reverse the effects of the intraoperative medication given to relax the muscles and how this period of recovery correlates with a function of the heart.
Interventions
- DEVICE TetraGraph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2023-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04619225
The ClinicalTrials.gov registry entry for NCT04619225 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TetraGraph is the first listed.
NCT04619225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04619225 about?
NCT04619225 is a clinical study titled "Cardiac Output and Recovery Time". The purpose of this research is to determine the time it takes to reverse the effects of the intraoperative medication given to relax the muscles and how this period of recovery correlates with a function of the heart.
What is the current status of trial NCT04619225?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2022-09-14. Estimated completion is 2023-01-13.
What interventions are being tested in trial NCT04619225?
The interventions under investigation include: TetraGraph (DEVICE).
Who is sponsoring clinical trial NCT04619225?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.